Determining Ethyl Glucuronide Cutoffs When Detecting Self-Reported Alcohol Use In Addiction Treatment Patients

BACKGROUND: Ethyl glucuronide (EtG) is an alcohol biomarker with potential utility as a clinical research and alcohol treatment outcome. Debate exists regarding the appropriate cutoff level for determining alcohol use, particularly with the EtG immunoassay. This study determined the EtG immunoassay...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Alcohol Clin Exp Res
Main Authors: Lowe, Jessica M., McDonell, Michael G., Leickly, Emily, Angelo, Frank A., Vilardaga, Roger, McPherson, Sterling, Srebnik, Debra, Roll, John, Ries, Richard K.
Formato: Artigo
Idioma:Inglês
Publicado: 2015
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4400217/
https://ncbi.nlm.nih.gov/pubmed/25866234
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/acer.12699
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares